Targeting the Secretory Pathway for Anti-Inflammatory Drug Development

E-ISSN： 1873-4294|6|2|165-178

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.6, Iss.2, 2006-01, pp. : 165-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insight into Drug Design and Development of Anti-inflammatory Agents

Clinical Anti-Inflammatory & Anti-Allergy Drugs, Vol. 2, Iss. 1, 2015-04 ,pp. : 67-78

Bentham Science Publishers

Access to resources Recommend Favorite

Cholinergic Anti-inflammatory Pathway and Stroke

Current Drug Delivery, Vol. 14, Iss. 4, 2017-07 ,pp. : 449-457

Bentham Science Publishers

Access to resources Recommend Favorite

New tuberculosis drug development: targeting the shikimate pathway

By Kapnick Senta M Zhang Ying

Expert Opinion on Drug Discovery, Vol. 3, Iss. 5, 2008-05 ,pp. : 565-577

Informa Healthcare

Access to resources Recommend Favorite

Immunopharmacology: anti-inflammatory therapy targeting transcription factors

By Pfeilschifter J. Muhl H.

European Journal of Pharmacology, Vol. 375, Iss. 1, 1999-06 ,pp. : 237-245

Elsevier

Access to resources Recommend Favorite

Anti-Inflammatory Mechanisms of Glucocorticoids Targeting Granulocytes

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 4, 2005-08 ,pp. : 455-463

Bentham Science Publishers

Access to resources Recommend Favorite